vTv Therapeutics
VTVT
$27.90
Share price
0.07%
Change (1 day)
2,900.00%
Change (1 year)
Categories
Revenue for vTv Therapeutics (VTVT)
Revenue in 2023 (TTM): N/A
In 2022 the company made a revenue of $2.01 M a decrease over the years 2021 revenue that were of $4 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for vTv Therapeutics from 2014 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
2023 (TTM)  | N/A | -100% |
| 2022 | $2.01 M | -49.61% |
| 2021 | $4 M | -37.56% |
| 2020 | $6.41 M | 132.05% |
| 2019 | $2.76 M | -77.77% |
| 2018 | $12.43 M | 4172.85% |
| 2017 | $0.29 M | -54.1% |
| 2016 | $0.63 M | 22.16% |
| 2015 | $0.51 M | -66.49% |
| 2014 | $1.54 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.86 B | N/A | 🇺🇸 USA |
 Onconova Therapeutics ONTX | $0.22 M | N/A | 🇺🇸 USA |